A composition of raltitrexed and a method of preparing the same

By preparing an amphiphilic polymer of chitosan surface amino-grafted polylactic acid and a carbon nanotube-modified targeted drug carrier, the problems of poor solubility and insufficient targeting of raltitrexed were solved, achieving efficient drug delivery and sustained release, improving therapeutic efficacy and reducing side effects.

CN121081650BActive Publication Date: 2026-05-29HONGGUAN BIO PHARMA CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
HONGGUAN BIO PHARMA CO LTD
Filing Date
2024-05-29
Publication Date
2026-05-29

Smart Images

  • Figure BDA0004864733680000091
    Figure BDA0004864733680000091
  • Figure BDA0004864733680000101
    Figure BDA0004864733680000101
  • Figure BDA0004864733680000102
    Figure BDA0004864733680000102
Patent Text Reader

Abstract

The application relates to the technical field of medicines, and discloses a composition of raltitrexed and a preparation method thereof. The composition of raltitrexed is a full-biodegradable amphiphilic polymer with hydrophilic chitosan and hydrophobic polylactic acid grafted as a carrier, and the composition is combined with carbon nanotubes and chitosan through pi-pi interaction and electrostatic adsorption. The carbon nanotubes have a large specific surface area and strong adsorption capacity, the folate has a targeting function, and the polylactic acid long chain has hydrophobicity. The raltitrexed drug is embedded in the micelle core of the copolymer, so that the encapsulation rate is greatly improved. The raltitrexed molecule contains O, N, S and other elements, can easily form a hydrogen bond with the amphiphilic copolymer, the hydrophobic end polylactic acid side chain can prolong the drug release time, achieve the purpose of slow release, reduce the drug toxicity and adverse reactions, the prepared composition is relatively stable in release, and the slow release effect is relatively ideal.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • CN1682726A

  • CN103610649A

  • CN1686138A